Sanofi-aventis has signed a research partnership with Aviesan, representing the first alliance of all the players of the academic healthcare research community in France.
Aviesan (the French Life Sciences and Healthcare Alliance) is comprised of the CEA, CNRS, INRA, INRIA, Inserm, Institut Pasteur, IRD, Conference of University Presidents and Conference of Regional and University Hospital CEOs.
The aim of the research partnership is to enhance scientific knowledge in the areas of life sciences and healthcare, to contribute to the strength of French research and to develop projects in areas such as ageing, immuno-inflammatory diseases, infectious diseases and regenerative medicine.
“This partnership with the National Alliance for Life Sciences and Healthcare is a major breakthrough in terms of public-private partnerships in France,” said Christopher A. Viehbacher, CEO of sanofi-aventis. “By pooling the creativity and expertise of a multitude of world-renowned researchers, we are sure that this fruitful collaboration will boost innovation in life sciences in France, and ultimately lead to major discoveries that will benefit patients.”
Pr. André Syrota, Chairman of Aviesan, added: “This partnership should enable us to better showcase French research abroad. We are very pleased to stand side-by-side with sanofi-aventis to conduct research from fundamental science to patient application.”